Calmodulin content and in vitro contractility of duodenum from streptozotocin-induced diabetic rats: effects of insulin therapy and calmodulin antagonism

European Journal of Pharmacology
Y OztürkN Yildizoğlu-Ari


The effects of experimental diabetes and insulin treatment on the decreased reactivity of isolated rat duodenum to KCl and calmidazolium, a specific calmodulin antagonist, were examined. After 8 weeks of streptozotocin diabetes, the contractile effect of KCl and the non-competitive antagonistic effect of calmidazolium against KCl on isolated rat duodenum were decreased. Calmodulin levels, as measured by radioimmunoassay, were also found to the decreased in duodenum from streptozotocin-diabetic rats. Neither impaired reactivity to KCl nor decreased calmodulin levels in diabetic rat duodenum were corrected by treatment with insulin (10 IU/kg for 20 days). Following insulin treatment, there was only a partial correction in the antagonistic effect of calmidazolium as shown by the increase in non-competitive antagonist affinity constant.


Oct 1, 1978·Diabetes·D J HoskingJ R Hampton
Nov 28, 1979·Biochemical and Biophysical Research Communications·H RosenbergS J Stohs
Aug 9, 1975·British Medical Journal·K E BrittonR P Ekins
Oct 1, 1992·Pharmacology & Toxicology·Y OztürkN Yildizoğlu-Ari
Mar 1, 1991·Trends in Biochemical Sciences·C W Heizmann, W Hunziker
May 1, 1990·Diabetes Research and Clinical Practice·Y OztürkV M Altan
Jan 1, 1990·General Pharmacology·C KarasuV M Altan
Feb 1, 1990·Archives of Internal Medicine·K I Ogbonnaya, R Arem
Apr 1, 1989·Journal of Cardiovascular Pharmacology·Y TakiguchiM Nakashima
Jan 1, 1989·Cell Calcium·R D Burgoyne, M J Geisow
Jan 1, 1989·General Pharmacology·V M AltanA T Ozçelikay
Sep 1, 1987·Pharmacological Research Communications·Y OztürkC Karasu
Dec 15, 1966·The New England Journal of Medicine·L A Katz, H M Spiro
Jan 1, 1980·Annals of the New York Academy of Sciences·L J Van EldikD M Watterson
Jan 1, 1980·Annals of the New York Academy of Sciences·B Perez de GraciaW L West
Jul 30, 1981·Biochemical and Biophysical Research Communications·K GietzenH Bader
Jan 1, 1980·Annual Review of Biochemistry·R S Adelstein, E Eisenberg
Nov 1, 1994·Canadian Journal of Physiology and Pharmacology·Y ZhangR S Moreland
Nov 1, 1994·Canadian Journal of Physiology and Pharmacology·W T Gerthoffer, J Pohl
Nov 1, 1994·Canadian Journal of Physiology and Pharmacology·J D CarmichaelG J Kargacin
Mar 1, 1994·Trends in Pharmacological Sciences·R J Flower, N J Rothwell
Sep 1, 1996·Journal of Diabetes and Its Complications·Y OztürkN Yildizoğlu-Ari
Apr 1, 1958·Annals of Internal Medicine·P KASSANDER
Mar 9, 1946·Journal of the American Medical Association·E P SHERIDAN, C C BAILEY


Sep 24, 2002·Arquivos de neuro-psiquiatria·Maria Montserrat D P FurlanMarcílio H de Miranda Neto

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.